2441 - 2450 of 4301 Drugs
Zymar (gatifloxacin ophthalmic solution)
Zymar (gatifloxacin ophthalmic solution) is a fluoroquinolone antibiotic used to treat eye infections caused by bacteria. Zymar is available in generic form.
Zymaxid (gatifloxacin ophthalmic solution)
Zymaxid (gatifloxacin) Ophthalmic Solution 0.5% is a fluoroquinolone antibiotic used to treat bacterial conjunctivitis.
Gattex (teduglutide [rdna origin] for injection)
Gattex (teduglutide [rDNA origin]) for Injection is a glucagon-like peptide-2 analog used for the treatment of adult patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.
GaviLyte-C (polyethylene glycol and electrolytes solution)
GaviLyte-C (PEG-3350, sodium sulfate, sodium bicarbonate, sodium chloride and potassium chloride) with flavor pack is a combination of an osmotic laxative and electrolytes indicated for bowel cleansing prior to colonoscopy or barium enema X-ray examination. GaviLyte-C is the generic of CoLyte.
GaviLyte-G (polyethylene glycol & electrolytes)
GaviLyte-G (PEG-3350, sodium sulfate, sodium bicarbonate, sodium chloride and potassium chloride) is a combination of an osmotic laxative and electrolytes indicated for bowel cleansing prior to colonoscopy and barium enema X-ray examination.
GaviLyte-H Tablets and Oral Solution (peg-3350, sodium chloride, sodium bicarbonate and potassium chloride)
GaviLyte-H and Bisacodyl delayed-release tablet, for oral use (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablet) is a combination of an osmotic laxative and a stimulant laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. GaviLyte-H is the generic of HalfLytely.
Gavreto (pralsetinib capsules)
Gavreto (pralsetinib) is a kinase inhibitor used to treat adult patients with metastatic rearranged during transfection (RET), fusion-positive, non-small cell lung cancer (NSCLC) as detected by an FDA approved test.
Gazyva (obinutuzumab injection)
Gazyva (obinutuzumab) Injection is a monoclonal antibody used in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL).
Iressa (gefitinib)
Iressa (gefitinib) is a tyrosine kinase inhibitor used for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.